GIP1R stimulating antibodies (North Coast)

N/A

Report date: 2025/03/20 16:12:01

Base Information

Drug NameGIP1R stimulating antibodies (North Coast)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionGlucose-Dependent Insulinotropic Polypeptide Receptor agonists
TargetsGlucose-Dependent Insulinotropic Polypeptide Receptor
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNorth Coast Biologics LLC
China Registration ClassN/A

Develop Information

Active CompaniesNorth Coast Biologics LLC
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A